Short answer
Inmune Bio, Inc. (INMB) filed an 8-K current report with the SEC on February 27, 2026 reporting Item 7.01 (Regulation FD Disclosure). Inmune Bio filed a Reg FD disclosure (Item 7.01), signaling material non-public information is being broadly released to maintain fair market access.
Inmune Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Inmune Bio filed a Reg FD disclosure (Item 7.01), signaling material non-public information is being broadly released to maintain fair market access
- Filing text contains no substantive disclosed information: full content likely resides in an accompanying exhibit (e.g., Exhibit 99.1)
- Investors should review the attached exhibit directly for the actual disclosed data, presentation, or announcement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inmune Bio, Inc. 8-K filings
Get the next INMB 8-K as it lands
Follow INMB for push alerts, or ask the research agent what this filing means.